Dr. Mario Mandalà received his medical degree from the Faculty of Medicine, Catholic University of Rome, Italy. He completed residency trainings in Medical Oncology and Haematology and since then he has consistently been active in medical research. He is currently associate professor of Medical Oncology at the University of Perugia
Since 2011 he chaired the scientific and organizing committees of the Clinical and Translational Research Working Group of the Italian Melanoma Intergroup (IMI), and from 2017 to 2019 he was secretary of IMI.
Since 2019 Dr Mandalà is the new elected president of the Italian Melanoma Intergroup (IMI), and recently has been appointed secretary of the EORTC melanoma group.
Dr Mandalà is a member of the ESMO committee of melanoma guidelines, and he is in the editorial board of several international journals
He has authored more than 190 publications and his major scientific interests are clinical and translational research on melanoma, gastrointestinal cancer and thromboembolic complications in cancer patients. Since 2008, he gave major contributions in ESMO, EORTC, ISTH, AIOM on the management of Melanoma and thromboembolic complications in cancer patients.